Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

AHA takes on cardiac amyloidosis | Have clinicians been wrong about PAD? | FDA OKs new AI for heart failure

News You Need to Know Today
AHA takes on cardiac amyloidosis | Have clinicians been wrong about PAD? | FDA OKs new AI for heart failure
Friday, May 29, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

American Heart Association takes on cardiac amyloidosis with new initiative

One of the project's biggest goals is helping clinicians identify patients in need of care earlier than ever.

READ MORE >
Video of Mathew S. Maurer, MD, director, Cardiac Amyloidosis Program, NewYork Presbyterian Hospital, explains how the American Hearty Association’s ATTR Amyloidosis Initiative is bringing together multidisciplinary teams to strengthen management of transthyretin amyloid cardiomyopathy (ATTR-CM). The goal is to catch more of these patients earlier and ensure they get timely care before they end up in advanced heart failure. #ATTR #Cardiacamyloidosis
Share on Twitter Share on Facebook Share on Linkedin

American Heart Association takes on cardiac amyloidosis with new initiative

Share on Twitter Share on Facebook Share on Linkedin
Video of Mathew S. Maurer, MD, director, Cardiac Amyloidosis Program, NewYork Presbyterian Hospital, explains how the American Hearty Association’s ATTR Amyloidosis Initiative is bringing together multidisciplinary teams to strengthen management of transthyretin amyloid cardiomyopathy (ATTR-CM). The goal is to catch more of these patients earlier and ensure they get timely care before they end up in advanced heart failure. #ATTR #Cardiacamyloidosis
One of the project's biggest goals is helping clinicians identify patients in need of care earlier than ever.
READ MORE >

Have clinicians been wrong about how they diagnose PAD?

The ankle-brachial index, a noninvasive diagnostic test for peripheral artery disease, may provide even more value than clinicians previously realized. 

READ MORE >
leg amputation below the knee
Share on Twitter Share on Facebook Share on Linkedin

Have clinicians been wrong about how they diagnose PAD?

Share on Twitter Share on Facebook Share on Linkedin
leg amputation below the knee
The ankle-brachial index, a noninvasive diagnostic test for peripheral artery disease, may provide even more value than clinicians previously realized. 
READ MORE >

FDA gives greenlight to new AI tool for managing heart failure patients

New AI-enabled software from Cardiosense estimates a patient's PCWP without the use of a catheter or implant. 

READ MORE >
CMS greenlights LDCT lung cancer screening
Share on Twitter Share on Facebook Share on Linkedin

FDA gives greenlight to new AI tool for managing heart failure patients

Share on Twitter Share on Facebook Share on Linkedin
CMS greenlights LDCT lung cancer screening
New AI-enabled software from Cardiosense estimates a patient's PCWP without the use of a catheter or implant. 
READ MORE >

Featured Articles

Diabetes drugs improve survival for patients with ‘broken hearts’

However, no significant difference was seen in heart failure hospitalization rates. The study's authors emphasized that more research on this topic is still necessary. 

READ MORE >
broken heart stethoscope Takotsubo syndrome
Share on Twitter Share on Facebook Share on Linkedin

Diabetes drugs improve survival for patients with ‘broken hearts’

Share on Twitter Share on Facebook Share on Linkedin
broken heart stethoscope Takotsubo syndrome
However, no significant difference was seen in heart failure hospitalization rates. The study's authors emphasized that more research on this topic is still necessary. 
READ MORE >

Prasugrel after PCI outperforms other common antiplatelet drugs

"Prasugrel provided the optimal balance between efficacy and safety," researchers noted in a new meta-analysis. 

READ MORE >
heart drugs with stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Prasugrel after PCI outperforms other common antiplatelet drugs

Share on Twitter Share on Facebook Share on Linkedin
heart drugs with stethoscope
"Prasugrel provided the optimal balance between efficacy and safety," researchers noted in a new meta-analysis. 
READ MORE >

AI tool helps remote monitoring clinics explore patient data

The new AI-enabled resource works like a search engine and delivers answers in seconds.

READ MORE >
AI healthcare doctor surgery procedure artificial intelligence
Share on Twitter Share on Facebook Share on Linkedin

AI tool helps remote monitoring clinics explore patient data

Share on Twitter Share on Facebook Share on Linkedin
AI healthcare doctor surgery procedure artificial intelligence
The new AI-enabled resource works like a search engine and delivers answers in seconds.
READ MORE >

Cardiology groups celebrate bill that could improve Medicare payments

Physicians from all specialties, not just cardiology, have been hoping for legislation like this for years.

READ MORE >
Congress in Washington, D.C., is working on legislation to possibly expand Medicare coverage payments for phjysicians.
Share on Twitter Share on Facebook Share on Linkedin

Cardiology groups celebrate bill that could improve Medicare payments

Share on Twitter Share on Facebook Share on Linkedin
Congress in Washington, D.C., is working on legislation to possibly expand Medicare coverage payments for phjysicians.
Physicians from all specialties, not just cardiology, have been hoping for legislation like this for years.
READ MORE >

Insulet recalls 7M insulin delivery pods due to safety risk

A total of 24 adverse safety incidents—including cases of diabetic ketoacidosis—have been linked to this issue.

READ MORE >
Insulet Corporation has announced a voluntary recall for specific lots of the pods associated with its Omnipod 5 Automated Insulin Delivery System
Share on Twitter Share on Facebook Share on Linkedin

Insulet recalls 7M insulin delivery pods due to safety risk

Share on Twitter Share on Facebook Share on Linkedin
Insulet Corporation has announced a voluntary recall for specific lots of the pods associated with its Omnipod 5 Automated Insulin Delivery System
A total of 24 adverse safety incidents—including cases of diabetic ketoacidosis—have been linked to this issue.
READ MORE >

In Case You Missed It

Resilia tissue developed by Edwards Lifesciences associated with long-term durability

Kevin Accola, MD, spoke to Cardiovascular Business about new 10-year data on the performance of surgical valves featuring Resilia tissue. The findings are good news for Edwards Lifesciences, which also includes the tissue on many of its TAVR devices.

READ MORE >
Kevin Accola, MD, a cardiac surgeon at Advent Health in Orlando, Florida, explains the 10-year results from the COMMENCE aortic trial that shows long-term durability and sustained performance of its Resilia surgical aortic valve. The data were presented at the American Association for Thoracic Surgery (AATS) 2026 annual meeting this week. #AATS #AATS26 #AATS2026
Share on Twitter Share on Facebook Share on Linkedin

Resilia tissue developed by Edwards Lifesciences associated with long-term durability

Share on Twitter Share on Facebook Share on Linkedin
Kevin Accola, MD, a cardiac surgeon at Advent Health in Orlando, Florida, explains the 10-year results from the COMMENCE aortic trial that shows long-term durability and sustained performance of its Resilia surgical aortic valve. The data were presented at the American Association for Thoracic Surgery (AATS) 2026 annual meeting this week. #AATS #AATS26 #AATS2026
Kevin Accola, MD, spoke to Cardiovascular Business about new 10-year data on the performance of surgical valves featuring Resilia tissue. The findings are good news for Edwards Lifesciences, which also includes the tissue on many of its TAVR devices.
READ MORE >

Heart experts concerned after Trump administration authorizes fruit-flavored e-cigarettes

This is the first time the FDA has authorized market access for non-tobacco, non-menthol electronic nicotine delivery systems. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Heart experts concerned after Trump administration authorizes fruit-flavored e-cigarettes

Share on Twitter Share on Facebook Share on Linkedin
This is the first time the FDA has authorized market access for non-tobacco, non-menthol electronic nicotine delivery systems. 
READ MORE >

Cannabis use increases risk of death, heart attack for ED patients

When patients land in the emergency room, a history of cannabis use may increase their risk of an adverse outcome.

READ MORE >
Emergency Department room ED ER EM
Share on Twitter Share on Facebook Share on Linkedin

Cannabis use increases risk of death, heart attack for ED patients

Share on Twitter Share on Facebook Share on Linkedin
Emergency Department room ED ER EM
When patients land in the emergency room, a history of cannabis use may increase their risk of an adverse outcome.
READ MORE >

In Other News

FDA issues early alert over black matter in IV lines

Manufacturer ICU Medical is aware of the issue, first flagged by an unnamed healthcare organization. The company and the FDA are asking providers to monitor IV lines for any signs of particulates.

READ MORE >
FDA issues recall of imaging systems
Share on Twitter Share on Facebook Share on Linkedin

FDA issues early alert over black matter in IV lines

Share on Twitter Share on Facebook Share on Linkedin
FDA issues recall of imaging systems
Manufacturer ICU Medical is aware of the issue, first flagged by an unnamed healthcare organization. The company and the FDA are asking providers to monitor IV lines for any signs of particulates.
READ MORE >

‘Advanced access’ scheduling pleases patients, strengthens PCPs

Primary care providers can significantly improve practice performance as well as patient satisfaction by making one workaday adjustment: leaving some appointment slots open to accommodate walk-ins throughout the day. 

READ MORE >
primary care doctor
Share on Twitter Share on Facebook Share on Linkedin

‘Advanced access’ scheduling pleases patients, strengthens PCPs

Share on Twitter Share on Facebook Share on Linkedin
primary care doctor
Primary care providers can significantly improve practice performance as well as patient satisfaction by making one workaday adjustment: leaving some appointment slots open to accommodate walk-ins throughout the day. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

News Alert: Medtronic recalls thousands of surgical devices
New IVL tech overcomes previous limitations | 3-year SMART data looks at TAVR outcomes | Artivion acquires Endospan for $135M
FDA approves next-gen mitral valve | Doctors are first in world to use new TAVR technique | Preventing a common complication
Key updates in PFA & beyond | More good IVL news for Boston Scientific | FDA approves new hypertension drug
Cardiologists scramble to prepare for new policy | Boston Scientific invests $1.5B in TAVR developer | FDA clears cath lab tech
The latest on PFA risks | EP catheters recalled | Doctors exempt from work visa freeze | Good news for Heartflow
Top 10 most popular cardiology video interviews this past month

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …3
    • Page 4
    • Page 5
    • Page 6
    • Current page 7
    • Page 8
    • Page 9
    • Page 10
    • Page 11 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup